Integrating scientific considerations into R&D project valuation

Nat Biotechnol. 2020 Jan;38(1):14-18. doi: 10.1038/s41587-019-0358-x.
No abstract available

MeSH terms

  • Antibodies / pharmacology
  • Antibodies / therapeutic use
  • Arthritis, Rheumatoid / drug therapy
  • Cytokines / metabolism
  • Humans
  • Investments
  • Research Personnel
  • Research*
  • Risk
  • Science*

Substances

  • Antibodies
  • Cytokines